Dienogest alone or dienogest combined with estrogens in the treatment of ovarian endometriomas, that is the question. A retrospective cohort study.
Authors:
- Benedetta OrsiniBOBenedetta Orsini
- Anna Chiara AruAAAnna Chiara Aru
- Jacopo LenziJLJacopo Lenzi
Preprint
- 10 April 2023
- preprint
- Published by Springer Nature in Research Square
Abstract
Purposeto compare the effects of Dienogest 2 mg (D) alone or combined with estrogens (D + ethinylestradiol 0.03 mg, D + EE; D + estradiol valerate 1–3 mg, D + EV) in terms of symptoms and endometriotic lesions variations.MethodsThis retrospective study included symptomatic patients in reproductive age with ultrasound diagnosis of ovarian endometriomas. Medical therapy for at least 12 months with D, D + EE or D + EV was required. Women were evaluated at baseline visit (V1) and after 6 (V2) and 12 months (V3) of therapy.Results297 patients were enrolled (156 in the D group, 58 in the D + EE group, 83 in the D + EV group). There were no differences between groups in terms of lesions mean diameter variation. No variations were detected in terms of lesions reduction when comparing the two estroprogestins, cyclic versus continuous estroprogestin regimens, D alone versus D + EE/D + EV administered continuously. When comparing D and D + EE/D + EV groups, a significant decrease of dysmenorrhea was detected in the D group than in D + EE/D + EV group. Conversely, the reduction of dysuria was more significative in the D + EE/D + EV groups rather than in the D group. Regarding tolerability, treatment associated side effects were reported by 16.2% patients. The most frequent one was uterine bleeding/spotting, significantly higher in the D + EV group.ConclusionDienogest alone or associated with estrogens (EE/EV) seems to be equally effective in reducing endometriotic lesions mean diameter. The reduction of dysmenorrhea was more significative when D was administered alone, while dysuria seems to improve more when D is associated with estrogens.Keywords
All Related Versions
This publication has 26 references indexed in Scilit:
- Systematic approach to sonographic evaluation of the pelvis in women with suspected endometriosis, including terms, definitions and measurements: a consensus opinion from the International Deep Endometriosis Analysis (IDEA) groupUltrasound in Obstetrics & Gynecology, 2016
- Safety and tolerability of dienogest in endometriosis: pooled analysis from the European clinical study programInternational Journal of Women's Health, 2015
- Ovarian Endometrioma: What the Patient NeedsJournal of Minimally Invasive Gynecology, 2014
- Modification of body composition and metabolism during oral contraceptives containing non-androgenic progestins in association with estradiol or ethinyl estradiolGynecological Endocrinology, 2014
- Dienogest in long-term treatment of endometriosisInternational Journal of Women's Health, 2011
- Endometriomas: their ultrasound characteristicsUltrasound in Obstetrics & Gynecology, 2010
- Recurrence of endometriosis and its controlHuman Reproduction Update, 2009
- Relations entre endométriose et algie pelvienne chronique : quel est le niveau de preuve ?Gynécologie Obstétrique & Fertilité, 2009
- Classification of Ovarian Endometriotic CystsInternational Journal of Gynecological Pathology, 2001
- Oestrogens and lower urinary tract functionMaturitas, 2000